Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of ...

Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. The company disappointed investors when it revised its ...

Beta Bionics plans to announce Q2 2025 financial results on July 29, followed by a conference call.

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing ...

Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010 ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

(RTTNews) - Evolent Health, Inc. (EVH) on Friday confirmed its second-quarter as well as full-year EBITDA outlook.

Tesla’s TSLA 1.17% global vehicle sales fell 13.5% in the second quarter compared with a year ago, continuing a steep slide in automotive sales, as the company tries to pivot to autonomous ...

Moderna plans to present these data at an upcoming medical conference and submit for peer-reviewed publication. The Company will engage with regulators on filing submissions for mRNA-1010. About ...